Liver-protecting injection for blood cancer patients on chemotherapy
Part of Digestive system clinical trials.
This study tests a medicine that may help protect the liver from damage caused by chemotherapy in people with blood cancers. If you're getting chemo and want extra liver support, this could be an option to discuss with your doctor.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You have a blood cancer like leukemia, lymphoma, or multiple myeloma.
- You've had at least one round of chemotherapy that can stress the liver.
- You'll receive the study drug (polyene phosphatidylcholine injection) to help prevent or treat liver damage.
- You may also take other standard liver-support medicines along with the study drug.
- You must have a liver function blood test within a week before and after starting the study treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a medicine called polyene phosphatidylcholine can help protect the liver from damage after surgery for liver cancer. It is for people who are having a specific type of keyhole surgery to remove part of the liver.
This trial tests whether phycocyanin, a natural supplement, can protect the liver before and after surgery to remove part of the liver. It is for people with a type of bile duct cancer who are already getting chemotherapy and other treatments before surgery.
This trial tests if a medication can protect the liver during chemotherapy for children and teenagers newly diagnosed with acute lymphoblastic leukemia (ALL). It aims to reduce liver damage caused by treatment.
This study tests whether a choline injection can help people with intestinal failure who need long-term intravenous nutrition (parenteral support). It may improve liver health and reduce complications from not getting enough choline through food.
This Phase 2 trial tests an injection medicine (F573) to see if it can improve people with liver injury, drug-related liver damage, or liver failure. You may be screened with blood tests, liver stiffness measurements, and possibly symptom checks.
This trial tests an experimental liver cell injection to see if it is safe and can help people with decompensated cirrhosis, a serious liver condition. If you qualify, you may receive this new treatment to potentially improve liver function.
Hear when a new Drug Induced Liver Injury trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.